Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide.
about
Molecular targets in arthritis and recent trends in nanotherapyContact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug deliveryalphaVbeta3-targeted copper nanoparticles incorporating an Sn 2 lipase-labile fumagillin prodrug for photoacoustic neovascular imaging and treatment.Dual-therapy with αvβ3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor model.Anti-angiogenic Nanotherapy Inhibits Airway Remodeling and Hyper-responsiveness of Dust Mite Triggered Asthma in the Brown Norway Rat.Trojan horses and guided missiles: targeted therapies in the war on arthritis.Recent advances in nanomedicines for the treatment of rheumatoid arthritis.A20 functions as mediator in TNFα-induced injury of human umbilical vein endothelial cells through TAK1-dependent MAPK/eNOS pathway.Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice.
P2860
Q26783466-8F65F024-6933-4BA5-A478-EC8CF2EA513CQ26795703-3545EC93-77A2-4EF5-9DAE-A08BD663A395Q34785222-C3AE8F53-42CE-44F7-A4AF-A1179834F37AQ36505441-FD7B2A26-E21B-40C8-9C34-94E9B51AC396Q37541992-BBF09B51-C3BA-4ACD-B5F9-87DE67CB6AB4Q38367194-15D622BB-A103-4668-A152-2EF18C33D494Q38669113-B34AC59A-4076-4F63-B7B2-FE3B8B5AA8A8Q42371521-D81D197A-D320-43E4-8855-DAB1B5ECD5C2Q48003088-DD2BF6B2-C19C-4308-9572-FB84D9916E9AQ48235332-70CB9863-4764-4100-A856-D57A89976732
P2860
Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Fumagillin prodrug nanotherapy ...... via endothelial nitric oxide.
@ast
Fumagillin prodrug nanotherapy ...... via endothelial nitric oxide.
@en
type
label
Fumagillin prodrug nanotherapy ...... via endothelial nitric oxide.
@ast
Fumagillin prodrug nanotherapy ...... via endothelial nitric oxide.
@en
prefLabel
Fumagillin prodrug nanotherapy ...... via endothelial nitric oxide.
@ast
Fumagillin prodrug nanotherapy ...... via endothelial nitric oxide.
@en
P2093
P2860
P356
P1433
P1476
Fumagillin prodrug nanotherapy ...... via endothelial nitric oxide.
@en
P2093
Christine T N Pham
Gregory M Lanza
Hui-fang Zhou
Huimin Yan
Luke E Springer
Samuel A Wickline
Xiaoxia Yang
P2860
P304
P356
10.1021/NN502372N
P407
P50
P577
2014-06-24T00:00:00Z